What did @itsamyosage actually say?
At six weeks on semaglutide, the creator reported losing 13 pounds, which she frames as averaging "about two pounds a week or so." She described two notable side effects: nausea that she says only appears when she hasn't eaten enough, and constipation she's managing with fiber supplements. On the positive side, she said "the food noise is completely vanished" and that she feels control over her nutrition "for the first time in like my entire adult life." She also emphasized a shift in mindset toward sustainable habits rather than just scale outcomes.
That's actually a more balanced take than most GLP-1 content on TikTok. She didn't promise a number, didn't recommend a dose, and acknowledged the rough parts. Credit where it's due.
Does the science back this up?
Mostly, yes. The 2021 STEP 1 trial (Wilding et al., New England Journal of Medicine) showed average weight loss of about 14.9% of body weight over 68 weeks in people on 2.4mg semaglutide weekly. Early weight loss in the first several weeks tends to be faster before the rate stabilizes, so 13 pounds at six weeks is plausible depending on starting weight, though it sits on the higher end of typical early-phase results.
The side effect profile she describes is well-documented. Nausea occurs in roughly 44% of semaglutide users according to STEP trial data, and constipation affects around 24%. Her observation that nausea correlates with undereating is consistent with clinical experience: semaglutide slows gastric emptying, and an empty stomach can amplify that effect. Fiber supplementation for constipation is a standard first-line recommendation, so she's doing the right thing there.
The "food noise" reduction she describes reflects the drug's mechanism. Semaglutide acts on GLP-1 receptors in the hypothalamus and brainstem, reducing appetite signaling and reward-driven eating behavior. Research by Blundell et al. (2017, Diabetes, Obesity and Metabolism) confirmed significant reductions in appetite and food cravings in semaglutide users compared to placebo.
What did they get wrong (or right)?
The creator got the core side effect picture right, and her fiber-for-constipation advice is sound. Her framing of nausea as a hunger cue is partially correct but worth nuancing: nausea on semaglutide isn't always about undereating. It can occur regardless of meal timing, especially during dose escalation phases. Treating every episode of nausea as a signal to eat more could lead someone to override their appetite suppression in counterproductive ways.
Her 2-pounds-per-week average is real, but she presents it as a steady, reliable rate. In practice, GLP-1 weight loss is not linear. Most people experience faster initial loss followed by plateau periods. The 2022 STEP 5 trial (Garvey et al., Nature Medicine) showed meaningful weight regain when semaglutide was discontinued, a reality worth knowing upfront.
What she got right: the psychological dimension. Her focus on habit formation and mental health alongside weight loss reflects what the clinical literature actually supports for long-term outcomes. That framing is more honest than most weight-loss content online.
What should you actually know?
Thirteen pounds in six weeks is attention-grabbing, but context matters significantly. Individual results depend on starting weight, dose level, diet, activity, and metabolic factors. The STEP trials showed that roughly 86% of participants lost at least 5% of body weight, but individual variation is wide.
Semaglutide is a prescription medication with a structured dose escalation protocol designed to minimize side effects. The nausea and constipation she described are common enough that clinical guidelines recommend slow titration specifically to reduce them. If you're experiencing persistent or severe GI symptoms, that's a conversation for your prescribing provider, not a reason to eat more or push through.
The "food noise" effect is real and clinically documented, but it does not mean the medication does the work alone. Studies consistently show that people who pair GLP-1 therapy with behavioral support maintain better long-term outcomes. Her instinct to focus on habits is not just feel-good framing; it's backed by evidence.
- Side effects are real and common: nausea affects roughly 44%, constipation roughly 24% of users in clinical trials.
- Early weight loss may feel faster than the long-term average, which is expected during initial dose escalation.
- Food noise reduction is a documented pharmacological effect, not just a mindset shift.
- Weight often returns after stopping semaglutide without sustained lifestyle support, per STEP extension data.